PRICE T ROWE ASSOCIATES INC /MD/ - IMMUNOVANT INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$28,027
+7454.4%
730,042
+3638.4%
0.00%
Q2 2023$371
-94.6%
19,528
-95.6%
0.00%
-100.0%
Q1 2023$6,875
+40.3%
443,204
+60.6%
0.00%0.0%
Q4 2022$4,899
-97.5%
275,999
+1116.9%
0.00%
Q3 2021$197,000
+5.9%
22,680
+28.8%
0.00%
Q2 2021$186,000
-32.9%
17,603
+2.0%
0.00%
Q1 2021$277,000
-97.9%
17,258
-94.0%
0.00%
-100.0%
Q4 2020$13,395,000
+85.2%
289,988
+41.1%
0.00%0.0%
Q3 2020$7,233,000205,5500.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 1,439,544$27,308,1508.29%
Logos Global Management LP 2,250,000$42,682,5005.80%
Deep Track Capital, LP 5,421,330$102,842,6304.76%
TCG Crossover Management, LLC 654,853$12,422,5612.04%
COMMODORE CAPITAL LP 900,000$17,073,0001.92%
ACUTA CAPITAL PARTNERS, LLC 141,755$2,689,0921.82%
Affinity Asset Advisors, LLC 260,000$4,932,2001.72%
HighVista Strategies LLC 180,320$3,420,6701.56%
Redmile Group, LLC 1,921,152$36,444,2531.40%
Perceptive Advisors 2,523,783$47,876,1641.39%
View complete list of IMMUNOVANT INC shareholders